Objectives and Measures Dimensions Nasal Resistance of Preterm and Term (MODERN)

Sponsor
Centre Hospitalier Intercommunal Creteil (Other)
Overall Status
Unknown status
CT.gov ID
NCT02815345
Collaborator
(none)
200
1
1
36
5.6

Study Details

Study Description

Brief Summary

During the resuscitation of preterm infants, withdrawal of non-invasive ventilation is difficult. In a recent study in children gestational age <30 weeks of amenorrhea (SA), definitive withdrawal rate from the first attempt to stop the non-invasive ventilation was 32% . In the same study, the median number of attempts before achieving a final withdrawal was 3 for children born before 28 weeks. The reasons for weaning failure are multiple and little studied. It seems that the type of interface used, mask or cannula, having an influence on the effectiveness of non-invasive ventilation . The nasal lesions induced by non-invasive ventilation are not uncommon, regardless of the interface used . In a recent randomized trial, they ranged from 40% to 50% depending on the type of nasal cannula and non-invasive ventilation mode. It is in this case external damage. But we assume that the breakdown causes internal lesions dependent on the pressure, humidity and flow. These factors are likely to generate a nasal obstruction, source intervention nurses who aspire nasal passages more or less traumatic.

The nasal cavities are often abused and, because of their key role in breathing, could be involved in the withdrawal of ventilatory failure

Condition or Disease Intervention/Treatment Phase
  • Device: Rhinometry
N/A

Detailed Description

The measurements of the nasal cavity dimensions are carried out by acoustic rhinometry (about 10 seconds for an acquisition). Measurement of nasal resistance is performed by rhinomanometry earlier (about a minute to a measure). They may be made to wakefulness or sleep since they do not require their participation. These measures will be carried at birth and then every 7 to 10 days (before the age of 28 days), if the child is still hospitalized.

During these measurements, the heart rate and oxygen saturation are collected by a measuring sensor transcutaneously.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Official Title:
Determination by a Noninvasive Method of the Geometric Dimensions of the Nasal Cavities of the Premature Newborn
Study Start Date :
Mar 1, 2014
Anticipated Primary Completion Date :
Mar 1, 2017
Anticipated Study Completion Date :
Mar 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Measure of the nasal cavity

The nasal cavity of all the included neonates will be measured using rhinometry during their hospitalization every weeks. So one to 8 measurement will be performed for each neonates. Some included neonates will also have rhinomanometry measurements.

Device: Rhinometry
An acoustic rhinometry device will be used to evaluate the area and the volume of the nasal cavities. Both nasal cavities will be measured except for patients with nasogastric tube.

Outcome Measures

Primary Outcome Measures

  1. Minimal cross sectional area measured by acoustic rhinometry [during the hospitalization of the infants, from birth to week 8]

    Acoustic rhinometry is a functional non-invasive procedure based on the sound reflection of acoustic waves on the nasal cavities. This procedure allows determining the geometry and the size of nasal cavities. The device is composed by a wave tube connected to a sound generator emitting series of acoustic impulsions. On this wave tube are laterally connected 2 microphones, themselves connected with a computer which analyzes the acoustic signal. These microphones detect the acoustic reflected wave.

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Day to 28 Days
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Affiliation to social security

  • Informed Parental Consent

  • Newborns term and preterm

  • Age less than or equal to 28 days

  • Signature of informed consent by both parents

Exclusion Criteria:
  • craniofacial malformation

  • Dyspnea (Silverman score> 3)

  • severe sepsis

  • life-threatened

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHI CRETEIL Neonatalogy Creteil France 94000

Sponsors and Collaborators

  • Centre Hospitalier Intercommunal Creteil

Investigators

  • Principal Investigator: Claude CD DANAN, MD, CHI Créteil Neonatalogy

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Claude Danan, Doctor, Centre Hospitalier Intercommunal Creteil
ClinicalTrials.gov Identifier:
NCT02815345
Other Study ID Numbers:
  • CHIC MODERN
First Posted:
Jun 28, 2016
Last Update Posted:
Jun 28, 2016
Last Verified:
Jun 1, 2016
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 28, 2016